These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 10921417)

  • 1. Influence of RNA titre and amino acid changes in the NS5A region of GB virus c/hepatitis G virus on the effectiveness of interferon therapy.
    Fujisawa T; Horiike N; Michitaka K; Onji M
    J Gastroenterol Hepatol; 2000 Jun; 15(6):632-9. PubMed ID: 10921417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of ribavirin plus interferon alpha on viraemia of GB virus-C/hepatitis G virus: comparison with interferon alpha alone.
    Kao JH; Lai MY; Chen W; Chen PJ; Chen DS
    J Gastroenterol Hepatol; 1998 Dec; 13(12):1249-53. PubMed ID: 9918434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GB virus C/hepatitis G virus infection in chronic hepatitis C patients with and without interferon-alpha therapy.
    Yu ML; Chuang WL; Dai CY; Chen SC; Lin ZY; Hsieh MY; Tsai JF; Wang LY; Chang WY
    Antiviral Res; 2001 Dec; 52(3):241-9. PubMed ID: 11675141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amino acid substitutions in NS5A region of GB virus C and response to interferon therapy.
    Kato T; Mizokami M; Orito E; Ohba K; Nakano T; Kondo Y; Tanaka Y; Ueda R; Mukaide M; Yasuda K; Iino S
    J Med Virol; 1999 Apr; 57(4):376-82. PubMed ID: 10089050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of interferon treatment response with GBV-C/HGV genomic RNA and anti-envelope 2 protein antibody.
    Tanaka T; Hess G; Schlueter V; Zdunek D; Tanaka S; Kohara M
    J Med Virol; 1999 Apr; 57(4):370-5. PubMed ID: 10089049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneity in E2 region of GBV-C/hepatitis G virus and hepatitis C virus.
    Kato T; Mizokami M; Nakano T; Orito E; Ohba K; Kondo Y; Tanaka Y; Ueda R; Mukaide M; Fujita K; Yasuda K; Iino S
    J Med Virol; 1998 Jun; 55(2):109-17. PubMed ID: 9598930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A competitive reverse transcription-polymerase chain reaction assay for quantitation of GB virus C/hepatitis G virus RNA that circumvents heteroduplex artifact.
    Liu F; Knight GB; Abel G; Agnello V
    J Virol Methods; 1999 May; 79(2):149-59. PubMed ID: 10381085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of interferon-alpha and ribavirin therapy on serum GB virus C/hepatitis G virus (GBV-C/HGV) RNA levels in patients chronically infected with hepatitis C virus and GBV-C/HGV.
    Lau JY; Qian K; Detmer J; Collins ML; Orito E; Kolberg JA; Urdea MS; Mizokami M; Davis GL
    J Infect Dis; 1997 Aug; 176(2):421-6. PubMed ID: 9237707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistent infection mechanism of GB virus C/hepatitis G virus differs from that of hepatitis C virus.
    Orii K; Tanaka E; Rokuhara A; Maruyama A; Ichijo T; Yoshizawa K; Kiyosawa K
    Intervirology; 2000; 43(3):139-45. PubMed ID: 11044807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GB virus type C NS5A sequence polymorphisms: association with interferon susceptibility and inhibition of PKR-mediated eIF2alpha phosphorylation.
    Xiang J; Martinez-Smith C; Gale M; Chang Q; Labrecque DR; Schmidt WN; Stapleton JT
    J Interferon Cytokine Res; 2005 May; 25(5):261-70. PubMed ID: 15871663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term follow-up of hepatitis G virus/GB virus C replication in liver during and after interferon therapy in patients coinfected with hepatitis C and G viruses.
    Shindo M; Arai K; Okuno T
    J Gastroenterol; 1999 Dec; 34(6):680-7. PubMed ID: 10588184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic heterogeneity and molecular epidemiology of GB virus C/hepatitis G virus in China.
    An P; Luo H; Lu T; O'Brien SJ; Winkler C
    J Hum Virol; 2000; 3(6):299-305. PubMed ID: 11100910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of patients with hepatitis C virus with and without GB virus C/hepatitis G virus co-infection and efficacy of interferon alfa.
    Enomoto M; Nishiguchi S; Fukuda K; Kuroki T; Tanaka M; Otani S; Ogami M; Monna T
    Hepatology; 1998 May; 27(5):1388-93. PubMed ID: 9581696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative study of 5' UTR and NS3R primers for the detection of GB virus C/hepatitis G virus RNA in Japanese.
    Tanaka H; Miyano M; Ueda H; Doi R; Mimura K; Nishide I; Yukawa S
    Liver; 1998 Dec; 18(6):378-82. PubMed ID: 9869391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence, implication, and viral nucleotide sequence analysis of GB virus-C/hepatitis G virus infection in acute fulminant and nonfulminant hepatitis.
    Wu JC; Chiang TY; Huang YH; Huo TI; Hwang SJ; Huang IS; Sheng WY; Lee SD
    J Med Virol; 1998 Oct; 56(2):118-22. PubMed ID: 9746066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic evolution of GB virus C/hepatitis G virus (GBV-C/HGV) under interferon pressure.
    Giménez-Barcons M; Sánchez-Fueyo A; Ampurdanés S; Puig-Basagoiti F; Guilera M; Ibáñez A; Clotet B; Martínez MA; Rodés J; Saiz JC; Sánchez-Tapias JM
    Antiviral Res; 2000 May; 46(2):157-70. PubMed ID: 10854667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GBV-C/HGV infection in chronic hepatitis C patients: its effect on clinical features and interferon therapy.
    Oshita M; Hayashi N; Mita E; Iio S; Hiramatsu N; Hijioka T; Kato M; Masuzawa M; Sasaki Y; Kasahara A; Hori M
    J Med Virol; 1998 Jun; 55(2):98-102. PubMed ID: 9598928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GBV-C/HGV infection in children with chronic hepatitis C.
    Komatsu H; Fujisawa T; Inui A; Sogo T; Morinishi Y; Miyagawa Y; Inui M
    J Med Virol; 1999 Oct; 59(2):154-9. PubMed ID: 10459149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of GBV-C hepatitis G RNA in chronic hepatitis C patients.
    Schleicher S; Chaves RL; Dehmer T; Gregor M; Hess G; Flehmig B
    J Med Virol; 1996 Sep; 50(1):71-4. PubMed ID: 8890043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GB virus C (GBV-C) infection in patients with chronic hepatitis C. Influence on liver disease and on hepatitis virus behaviour: effect of interferon alfa therapy.
    Pawlotsky JM; Roudot-Thoraval F; Muerhoff AS; Pellerin M; Germanidis G; Desai SM; Bastie A; Darthuy F; Rémiré J; Zafrani ES; Soussy CJ; Mushahwar IK; Dhumeaux D
    J Med Virol; 1998 Jan; 54(1):26-37. PubMed ID: 9443106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.